BioHarvest Sciences Inc. reported Q1 2025 revenue of $7.8M, missed analyst consensus of $8.5M by $697.1K. Diluted EPS came in at $-0.13, beat the $-0.15 consensus by $0.02.
Filings will appear here once submitted to SEC EDGAR.
Common questions about BioHarvest Sciences Inc.'s Q1 2025 earnings report.
BioHarvest Sciences Inc. (BHST) reported Q1 2025 earnings on May 15, 2025 after market close.
BioHarvest Sciences Inc. reported revenue of $7.8M and diluted EPS of $-0.13 for Q1 2025.
Revenue missed the consensus estimate of $8.5M by $697.1K. EPS beat the consensus estimate of $-0.15 by $0.02.